EUIPO trademark

Letrozole SIE

Opposition periodEUIPOWord markClass 5

"Letrozole SIE" is a word mark owned by Laboratorios Farmaceuticos Rovi, S.A., filed at the EUIPO on February 3, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).

View Laboratorios Farmaceuticos Rovi, S.A. portfolioGet this data via the API
Official EUIPO record
Letrozole SIE
Word mark as filed with the EUIPO
Status
Opposition period
Since February 3, 2026
Filed
February 3, 2026
Registered
Not yet
Expires
Not recorded
Application no.
019312173
Registration no.
Not yet
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns Letrozole SIE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Laboratorios Farmaceuticos Rovi, S.A.

ROVI

595 trademarks in the portfolioView company

Representative

Balder IP Law

Balder IP Law

Goods and services

What the mark covers

The products and services Letrozole SIE is filed for, grouped by Nice class.

  • Pharmaceutical products, including antibiotics, analgesics, anesthetics, amino acids for medical use, antiseptics, sedatives, eye drops, digestive aids for pharmaceutical use, laxatives, narcotics, chemicals for medical use, pharmaceutical chemicals, tonics (medicines), sedatives, sleeping pills, antipsychotics, serums, hormones, contraceptives; vaccines, syringes, vials, cartridges, or ampoules for medical purposes containing pharmaceutical products; pharmaceutical implants; sustained-release drugs; oncology preparations; preparations for the treatment of central nervous system disorders; preparations for the treatment of schizophrenia; preparations for the treatment of hormonal disorders; preparations for the treatment of allergies, for the treatment of skin conditions, thrombosis, coagulation disorders, infections, influenza, pain, and inflammation; tranquilizers, prescription synthetic narcotics, antidepressants, anxiolytics; chemical products for medical use that are pharmaceutical products for the treatment of schizophrenia; pharmaceutical-chemical products for the treatment of central nervous system disorders; pre-filled syringes for medical use; pharmaceutical products for the treatment of breast cancer in postmenopausal women; hormonal preparations for the treatment of breast cancer in postmenopausal women; hormones for medical use; pharmaceutical products for the treatment of hormonal disorders; anticancer preparations based on hormones; hormonal preparations for pharmaceutical use

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Decision 019312173 (REFUSAL)
FAQ

About Letrozole SIE

Who owns the trademark "Letrozole SIE"?

The EUIPO trademark "Letrozole SIE" (application 019312173) is owned by Laboratorios Farmaceuticos Rovi, S.A.

What is the status of "Letrozole SIE"?

Its status at the EUIPO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Letrozole SIE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d490e-56e3-72d9-9b7d-a57e26d4efce
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d490e-56e3-72d9-9b7d-a57e26d4efce",
  "object": "trademark",
  "mark_text": "Letrozole SIE",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "EM",
  "application_number": "019312173",
  "filing_date": "2026-02-03",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "LABORATORIOS FARMACEUTICOS ROVI, S.A.",
      "entity_id": "ent_019eb705-a414-7319-8866-22abf5c7dc29"
    }
  ]
}